 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 11/25/2020 |
$1.40 |
$1.43 |
$1.38 |
$1.41 |
1.17M | | 11/27/2020 |
$1.48 |
$1.75 |
$1.46 |
$1.65 |
5.20M | | 11/30/2020 |
$1.76 |
$1.79 |
$1.52 |
$1.62 |
3.92M | | 12/01/2020 |
$1.64 |
$1.65 |
$1.50 |
$1.52 |
3.11M | | 12/02/2020 |
$1.52 |
$1.58 |
$1.46 |
$1.56 |
1.78M |
|
|
| Abeona Therapeutics is a biopharmaceutical company developing gene and cell therapies for rare genetic diseases. Co.'s clinical programs consist of: EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; and ABO-101, an AAV-based gene therapy for Sanfilippo syndrome type B. Co. has other AAV-based gene therapies in developmental stages designed to treat the CLN1 and CLN3 forms of Batten Disease, cystic fibrosis and retinal diseases. Co. is also developing AAV-based gene therapies through its AIM™ capsid platform and internal AAV vector research programs. |
|
|
Abeona Therapeutics (ABEO) has the following price history information. Looking back at ABEO historical stock prices for the last five trading days, on November 25, 2020, ABEO opened at $1.40, traded as high as $1.43 and as low as $1.38, and closed at $1.41. Trading volume was a total of 1.17M shares. On November 27, 2020, ABEO opened at $1.48, traded as high as $1.75 and as low as $1.46, and closed at $1.65. Trading volume was a total of 5.20M shares. On November 30, 2020, ABEO opened at $1.76, traded as high as $1.79 and as low as $1.52, and closed at $1.62. Trading volume was a total of 3.92M shares. On December 01, 2020, ABEO opened at $1.64, traded as high as $1.65 and as low as $1.50, and closed at $1.52. Trading volume was a total of 3.11M shares. On December 02, 2020, ABEO opened at $1.52, traded as high as $1.58 and as low as $1.46, and closed at $1.56. Trading volume was a total of 1.78M shares.
ABEO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Abeona Therapeutics shares, starting with a $10,000 purchase of ABEO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
12/03/2010 |
|
| End date: |
12/02/2020 |
|
| Start price/share: |
$2.90 |
|
| End price/share: |
$1.56 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-46.21% |
|
| Average Annual Total Return: |
-6.01% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$5,378.60 |
|
| Years: |
10.01 |
|
|
|
| Date |
Close |
| 11/25/2020 | $1.41 | | 11/27/2020 | $1.65 | | 11/30/2020 | $1.62 | | 12/01/2020 | $1.52 | | 12/02/2020 | $1.56 |
|
|
